ReaGenics
Optimizing Nature’s Gifts: Growing plants better.
ABOUT US
ReaGenics is pioneering a novel plant cell bioreactor production for the mass-scale multiplication of molecules. This eliminates the need to grow plants on an industrial scale for pharma-grade, botanically- derived molecules. Leveraging success with patented technology for multiplication and manipulation of plant cells, ReaGenics is applying its innovative technology to different plants allowing for consistent, controllable, and patentable formulation.
Active Markets
Plant Proteins
Cosmetics Molecules
Nutraceuticals Ingredients
Optimizing Nature’s gifts:
Growing Plants Better
Our world urgently needs a way to keep up with the growing demands of medicines, food supply chains, and the problem of so many of the world’s plant species on their way to extinction. We believe ReaGenics will be part of the solution to ensure these global needs and challenges are met.
By harnessing ancient knowhow from the Far-East, Africa, and Europe and applying cutting edge technologies, ReaGenics aims to disrupt the biotech industry and forever plant its footprint in global ecology.
WHO WE ARE
ReaGenics Research is an Israeli company focused on R&D rooted in cell tissue culturing aiming to be a market leader for a range of nutraceutical, food, pharmaceutical, medical and wellness products.
WHAT WE DO
ReaGenics is developing a technology platform that efficiently and safely grows to scale organic plant molecules in bioreactors.
Most Disruptive
Global Biotech Company
2021
